SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-044033
Filing Date
2018-11-29
Accepted
2018-11-29 16:01:44
Documents
6
Period of Report
2018-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s002554x6_8k.htm 8-K 28833
2 EXHIBIT 1.1 s002554x6_ex1-1.htm EX-1.1 285015
3 EXHIBIT 5.1 s002554x6_ex5-1.htm EX-5.1 6940
4 EXHIBIT 10.1 s002554x6_ex10-1.htm EX-10.1 53786
5 s002554x6_ex5-1footer.jpg GRAPHIC 30438
6 s002554x6_ex5-1header.jpg GRAPHIC 89693
  Complete submission text file 0001140361-18-044033.txt   541482
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 181208508
SIC: 2834 Pharmaceutical Preparations